MSB 1.36% $1.12 mesoblast limited

Ann: Update on BLA for Graft Versus Host Disease, page-205

  1. 7,514 Posts.
    lightbulb Created with Sketch. 6768
    The serial baiter here calling MSB out for 'thuggery'. You mean in not wanting to do an RCT given the deaths in the control arm? That thuggery?

    "The resubmission also included a post-hoc propensity matched study showing 6 month survival was 67% with remestemcel-L vs 10% with other unapproved therapies in highest-risk patients as identified using the Mount Sinai Acute GVHD International Consortium (MAGIC)."

    Yep, pure thuggery, wanting to not be involved in the swift death of say 33 patients on a 50 patient control arm in an RCT.

    Perhaps your touching concern for the FDA, so nastily picked on by MSB, might be better served for the patients dying.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.12
Change
0.015(1.36%)
Mkt cap ! $1.278B
Open High Low Value Volume
$1.13 $1.16 $1.10 $7.169M 6.411M

Buyers (Bids)

No. Vol. Price($)
4 7296 $1.12
 

Sellers (Offers)

Price($) Vol. No.
$1.12 43068 1
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.